Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.780
-0.040 (-2.20%)
At close: Sep 26, 2025, 4:00 PM EDT
1.820
+0.040 (2.25%)
After-hours: Sep 26, 2025, 4:00 PM EDT
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $174.16 million as of September 26, 2025. Its market cap has decreased by -5.60% in one year.
Market Cap
174.16M
Enterprise Value
135.57M
1-Year Change
-5.60%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since April 25, 2013, Innate Pharma's market cap has increased from $125.22M to $174.16M, an increase of 39.09%. That is a compound annual growth rate of 2.69%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |